Skip to main content
OpenTrials

Clinical trial condition

Stage IVA Nasopharyngeal Keratinizing Squamous Cell Carcinoma

Explore clinical trials studying Stage IVA Nasopharyngeal Keratinizing Squamous Cell Carcinoma. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Stage IVA Nasopharyngeal Keratinizing Squamous Cell Carcinoma trial results

Completed

Ficlatuzumab w/wo Cetuximab in Patients w/Cetuximab-Resistant, Recurrent or Metastatic Head/Neck Squamous Cell Carcinoma

NCT03422536

Conditions
Carcinoma, Carcinoma, Squamous Cell, HNSCC, +41 more
Locations
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
View Trial Details

Related conditions